MiniMed short interest estimated at 99% of float as share-swap arbitrage tightens supply
AI Market Summary
Ortex data showing ~99% of MiniMed's float sold short likely reflects event-driven arbitrage tied to Medtronic's tax-free share exchange rather than a pure bearish view. With Medtronic owning ~90% and an exchange offer far exceeding MiniMed's tradable float, arbitrageurs can buy MDT, tender, and short MMED ahead of settlement. The setup can drive extreme securities-lending tightness and atypical short-interest prints.
Impact level
● Low
Affected assets
NCSINASDAQ1002USD/USDT+0.14%
AI Insight · NCSINASDAQ1002USD/USDTAI Insight
● Neutral
Trade now
⚠️ AI-generated insights are based on news content and are provided for informational purposes only. They do not constitute investment advice or represent the views of BingX. Investing involves risk. Please trade responsibly.
Data provider Ortex estimates that about 99% of MiniMed Group Inc.’s public float has been sold short, a sharp jump from prior levels. Ortex’s securities-lending data show borrow availability at just 0.08% of short interest. The report says the extreme figures may reflect arbitrage tied to Medtronic’s 90% stake and its stock-for-stock exchange offer, rather than a straightforward bearish bet.
